Ingredient

Alpha Lipoic Acid (ALA)

Updated September 19, 2026 · By Theo Marchetti

The Short Answer

Alpha-lipoic acid (ALA) is an organosulfur compound that serves as a cofactor in mitochondrial energy metabolism and functions as a potent antioxidant in both water- and fat-soluble environments. A 2020 dose-response meta-analysis found ALA supplementation significantly reduces obesity risk, and a 2026 meta-analysis confirmed dose-dependent effects on cardiometabolic risk factors. The most commonly studied dose for body weight outcomes is 600 mg per day. ALA is one of the better-evidenced ingredients for metabolic support — but requires doses that proprietary blends rarely accommodate.

What is Alpha Lipoic Acid (ALA)?

Alpha-lipoic acid (ALA), also known as thioctic acid, is a naturally occurring organosulfur compound synthesized in small amounts by the human body. It functions as a cofactor for mitochondrial enzyme complexes involved in energy production — specifically pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are essential for converting nutrients into ATP. Unlike most antioxidants that work in either water-soluble (vitamin C) or fat-soluble (vitamin E) environments, ALA is amphipathic — active in both — earning it the descriptor 'universal antioxidant.' It is available in two forms: R-lipoic acid (the biologically active enantiomer) and S-lipoic acid (synthetic). Most supplements contain a racemic mixture (R/S-ALA); some premium products offer R-lipoic acid alone for improved bioavailability.

How it works

ALA's metabolic relevance operates through multiple pathways. As a mitochondrial cofactor, it directly participates in cellular energy production. Its antioxidant activity helps protect mitochondrial membranes from oxidative damage, potentially maintaining metabolic efficiency. ALA has been shown to activate AMPK — the same metabolic switch targeted by berberine and exercise — which promotes glucose uptake and fatty acid oxidation. It also regenerates other antioxidants (vitamins C and E, glutathione, coenzyme Q10), creating a cascade effect. In clinical studies, ALA supplementation has been associated with reduced body weight and improved insulin sensitivity, with effects appearing to be dose-dependent.

What the evidence says

Alpha-lipoic acid has a stronger evidence base for weight and metabolic outcomes than most antioxidant supplements. Multiple meta-analyses have evaluated its effects on body weight, BMI, and cardiometabolic risk factors, with consistent findings of dose-dependent benefits.

Effective dosage

Clinical studies for metabolic and body weight endpoints typically use 300–1,800 mg per day, with 600 mg/day being the most commonly studied dose for body composition outcomes. Higher doses (1,200–1,800 mg/day) have been used in diabetic neuropathy trials. A 2020 dose-response meta-analysis confirmed that the relationship between ALA dose and obesity risk reduction is dose-dependent — higher doses produced more consistent effects.

This creates a structural problem for proprietary blends. When six ingredients share 276 mg, even if ALA received the entire allocation — which it cannot — it would deliver less than half of the minimum studied dose (600 mg). In reality, ALA's share of a 276 mg six-way blend is likely 20–60 mg, approximately 10–30 times below the clinically studied range.

Safety and interactions

ALA is generally well tolerated at doses up to 1,800 mg/day in clinical trials. The most commonly reported side effects are gastrointestinal: nausea, stomach discomfort, and diarrhea, particularly at higher doses or when taken on an empty stomach. Taking ALA with food reduces GI symptoms but may also reduce absorption.

Drug interactions: ALA can lower blood sugar and may enhance the effects of insulin and oral hypoglycemics — dose adjustment of diabetes medications may be necessary under physician guidance. ALA may also interact with thyroid medications (levothyroxine) by reducing their absorption; separate administration by at least 4 hours.

ALA is not recommended during pregnancy or breastfeeding due to insufficient safety data. Individuals with thiamine (vitamin B1) deficiency should address the deficiency before starting ALA supplementation, as ALA may exacerbate thiamine-related issues.

Frequently Asked Questions